The merger is complete and ASRT is delisted. Convertible note holders must decide by July 16, 2026 whether to convert (~$382.58 per $1,000 principal) or require repurchase at 100% plus accrued interest by July 17, 2026. No further trading in ASRT common stock.
Price Chart
Executive Summary
Assertio Holdings completed its acquisition by Zydus Lifesciences on June 16, 2026. Shareholders received $23.50 per share in cash, the stock was delisted from Nasdaq, and the company became a wholly-owned subsidiary of Zydus. The convertible notes were modified to allow conversion into cash and a repurchase option was triggered.
Key Financial Metrics
Key Facts
- Tender offer expired June 15, 2026 with 4,286,488 shares (66.32% of outstanding) validly tendered
- Merger closed June 16, 2026 under DGCL Section 251(h) without stockholder vote
- Each share converted into right to receive $23.50 in cash
- Stock delisted from Nasdaq effective before market open on June 16, 2026
- All prior directors resigned; Ravi Yadavar and Punit Patel appointed as new directors
- All prior officers ceased; new officers appointed by Parent
- Certificate of incorporation and bylaws amended and restated
- First Supplemental Indenture executed for $40M 6.50% Convertible Senior Notes due 2027
- Notes conversion changed to cash: ~$382.58 per $1,000 principal; holders have repurchase right at 100% plus accrued interest
Financial Impact
Shareholders received $23.50 per share in cash; total equity value approximately $152M based on 6.46M shares outstanding
Risk Factors
- Convertible note holders who fail to act by deadlines may lose optionality
- Dissenting shareholders pursuing appraisal rights face uncertain outcome
- Delisting eliminates liquidity for any remaining untendered shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-074619 |
| Document: tm2617883d1_ex3-2.htm | 0001104659-26-074619 |
| Document: tm2617883d1_8k.htm | 0001104659-26-074619 |
| Document: tm2617883d1_ex4-1.htm | 0001104659-26-074619 |
| Document: tm2617883d1_ex99-1.htm | 0001104659-26-074619 |
| Document: tm2617883d1_ex3-1.htm | 0001104659-26-074619 |
| Document: 0001104659-26-074619-index-headers.html | 0001104659-26-074619 |
| Document: 0001104659-26-074619-index.html | 0001104659-26-074619 |
| Document: 0001104659-26-074619.txt | 0001104659-26-074619 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 7, 2026 15w ago | 25-NSE | — | awaiting T+20 | — | — |
Jun 26, 2026 17w ago | 15-12G | $23.50 | awaiting T+20 | — | — |
Jun 18, 2026 18w ago | EFFECT | $23.50 | awaiting T+20 | — | — |
Jun 16, 2026 18w ago | 8-K | $23.50 | awaiting T+20 | — | — |
May 18, 2026 23w ago | 8-K | $23.32 $23.50 | ▲ +0.77% | ▼ −0.81% | — |
May 8, 2026 24w ago | 8-K | $22.50 $23.44 | ▲ +4.18% | ▲ +4.15% | — |
May 5, 2026 24w ago | 8-K | $22.16 $23.45 | ▲ +5.82% | ▲ +0.87% | — |
May 4, 2026 25w ago | 8-K | $21.61 $23.43 | ▲ +8.42% | ▲ +2.78% | — |
Apr 29, 2026 25w ago | 8-K | $18.43 $23.44 | ▲ +27.18% | ▲ +21.96% | — |
Apr 9, 2026 28w ago | 8-K | $18.02 $22.20 | ▲ +23.20% | ▲ +15.63% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers